IMB Dx, Inc.

Research IMB Dx, Inc. (461030.KQ) on Bullrun: market cap KRW 37.34B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker461030.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryDiagnostics & Research
CurrencyKRW
Market capKRW 37.34B
Financial periodQ2 2026
RevenueKRW 1.51B
Net income-KRW 1.06B
Free cash flow-KRW 1.55B
Gross margin43.8%

Valuation Snapshot

latest market cap is KRW 37.34B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 37.34B	n/a	n/a	n/a

Dividend history

About IMB Dx, Inc.

IMB Dx, Inc. provides liquid biopsy platform in South Korea. It offers AlphaLiquid Platform that provides circulation-tumor DNA-based precision diagnostics solutions across various stages of cancer for patients, survivors, and individuals; AlphaLiquid HRR for diagnostics of targeted therapies, utilizing liquid biopsy profiling technology; and AlphaLiquid 100 test, a tool that enables the detection of biomarkers across 118 cancer-related genes through one blood test.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

GeneMatrix Inc. (109820.KQ) Genoray Co., Ltd. (122310.KQ) GC Cell Corporation (144510.KQ) Optipharm.CO.,LTD (153710.KQ) Dx & Vx Co., Ltd. (180400.KQ) Cytogen, Inc. (217330.KQ) ZGOO Holdings Co., Ltd. (221800.KQ) Protia Inc. (303360.KQ) P&K Skin Research Center Co., Ltd. (347740.KQ) Genesystem Co., Ltd. (363250.KQ) Noul Co.,Ltd. (376930.KQ) Coreline Soft Co., Ltd. (384470.KQ)

Frequently asked questions

What is IMB Dx, Inc.'s market cap?

IMB Dx, Inc.'s market capitalization is KRW 37.34B.